Supporting shared decision making in schizophrenia

Learning my options and sharing decisions about Schizophrenia. 

Please contact your Lundbeck or Otsuka Representative to learn more about supporting shared decision making in Schizophrenia.

AU-NOTPR-0527. March 2022.

  • Box
    Body

    Abilify Maintena PBS Information: Authority required (STREAMLINED). Code: 4246 for schizophrenia.
    This product is not listed on the PBS for the treatment of bipolar 1 disorder.

  • text
    Body

    Please review Approved Product Information before prescribing.
    Product Information is available by calling Lundbeck on 1300 721 277 or by clicking:

    Abilify Maintena PI

    Abilify Maintena is a registered trademark of Otsuka Pharmaceutical Co., Ltd. Abilify Maintena is co-commercialised by Lundbeck Australia and Otsuka Australia Pharmaceutical Pty Limited.